Engineering mammalian cells to seek senescence-associated secretory phenotypes.

Abstract excerpt

Since the removal of senescent cells in model organisms has been linked to rejuvenation and increased lifespan, senotherapies have emerged to target senescent cells for death. In particular, interleukin-6 (IL6) is a prominent senescence-associated secretory phenotype (SASP) and, thus, seeking IL6 could potentially localize engineered cells to senescent cells for therapeutic intervention. Here, we engineered a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calcium Signaling
• Share to Cell Death
• Share to Cell Fusion